vs
Orthofix Medical Inc.（OFIX）与Piedmont Realty Trust, Inc.（PDM）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Piedmont Realty Trust, Inc.的1.5倍（$219.9M vs $143.3M），Orthofix Medical Inc.净利率更高（-1.0% vs -31.4%，领先30.4%），Orthofix Medical Inc.同比增速更快（2.0% vs 0.4%），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 0.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Piedmont Realty Trust是一家公开上市的房地产投资信托（REIT），主要持有、运营和投资美国高增长大都会区的优质写字楼资产，服务科技、专业服务、医疗等多个行业的企业租户，通过战略资产管理和投资组合优化为利益相关方提供稳定长期回报。
OFIX vs PDM — 直观对比
营收规模更大
OFIX
是对方的1.5倍
$143.3M
营收增速更快
OFIX
高出1.5%
0.4%
净利率更高
OFIX
高出30.4%
-31.4%
两年增速更快
OFIX
近两年复合增速
0.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $143.3M |
| 净利润 | $-2.2M | $-45.0M |
| 毛利率 | 71.1% | — |
| 营业利润率 | 0.2% | — |
| 净利率 | -1.0% | -31.4% |
| 营收同比 | 2.0% | 0.4% |
| 净利润同比 | 92.4% | -27.9% |
| 每股收益（稀释后） | $-0.05 | $-0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXPDM
| Q1 26 | — | $143.3M | ||
| Q4 25 | $219.9M | $142.9M | ||
| Q3 25 | $205.6M | $139.2M | ||
| Q2 25 | $203.1M | $140.3M | ||
| Q1 25 | $193.6M | $142.7M | ||
| Q4 24 | $215.7M | $143.2M | ||
| Q3 24 | $196.6M | $139.3M | ||
| Q2 24 | $198.6M | $143.3M |
净利润OFIXPDM
| Q1 26 | — | $-45.0M | ||
| Q4 25 | $-2.2M | $-43.2M | ||
| Q3 25 | $-22.8M | $-13.5M | ||
| Q2 25 | $-14.1M | $-16.8M | ||
| Q1 25 | $-53.1M | $-10.1M | ||
| Q4 24 | $-29.1M | $-30.0M | ||
| Q3 24 | $-27.4M | $-11.5M | ||
| Q2 24 | $-33.4M | $-9.8M |
毛利率OFIXPDM
| Q1 26 | — | — | ||
| Q4 25 | 71.1% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 68.7% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 68.7% | — | ||
| Q2 24 | 67.8% | — |
营业利润率OFIXPDM
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | — | ||
| Q3 25 | -8.3% | — | ||
| Q2 25 | -7.9% | — | ||
| Q1 25 | -25.2% | — | ||
| Q4 24 | -5.3% | — | ||
| Q3 24 | -9.6% | — | ||
| Q2 24 | -12.5% | — |
净利率OFIXPDM
| Q1 26 | — | -31.4% | ||
| Q4 25 | -1.0% | -30.3% | ||
| Q3 25 | -11.1% | -9.7% | ||
| Q2 25 | -6.9% | -12.0% | ||
| Q1 25 | -27.4% | -7.1% | ||
| Q4 24 | -13.5% | -20.9% | ||
| Q3 24 | -13.9% | -8.3% | ||
| Q2 24 | -16.8% | -6.8% |
每股收益（稀释后）OFIXPDM
| Q1 26 | — | $-0.10 | ||
| Q4 25 | $-0.05 | $-0.34 | ||
| Q3 25 | $-0.57 | $-0.11 | ||
| Q2 25 | $-0.36 | $-0.14 | ||
| Q1 25 | $-1.35 | $-0.08 | ||
| Q4 24 | $-0.76 | $-0.25 | ||
| Q3 24 | $-0.71 | $-0.09 | ||
| Q2 24 | $-0.88 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $2.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $450.0M | $1.5B |
| 总资产 | $850.6M | $4.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OFIXPDM
| Q1 26 | — | $2.3M | ||
| Q4 25 | $82.0M | $731.0K | ||
| Q3 25 | $62.9M | $3.0M | ||
| Q2 25 | $65.6M | $3.3M | ||
| Q1 25 | $58.0M | $2.9M | ||
| Q4 24 | $83.2M | $109.6M | ||
| Q3 24 | $30.1M | $133.6M | ||
| Q2 24 | $26.4M | $138.5M |
总债务OFIXPDM
| Q1 26 | — | — | ||
| Q4 25 | — | $2.2B | ||
| Q3 25 | $157.2M | $2.2B | ||
| Q2 25 | $157.0M | $2.2B | ||
| Q1 25 | $156.9M | $2.2B | ||
| Q4 24 | $157.0M | $2.2B | ||
| Q3 24 | $118.5M | $2.2B | ||
| Q2 24 | $118.0M | $2.2B |
股东权益OFIXPDM
| Q1 26 | — | $1.5B | ||
| Q4 25 | $450.0M | $1.5B | ||
| Q3 25 | $442.5M | $1.5B | ||
| Q2 25 | $458.3M | $1.5B | ||
| Q1 25 | $458.3M | $1.6B | ||
| Q4 24 | $503.1M | $1.6B | ||
| Q3 24 | $525.9M | $1.6B | ||
| Q2 24 | $546.0M | $1.7B |
总资产OFIXPDM
| Q1 26 | — | $4.0B | ||
| Q4 25 | $850.6M | $4.0B | ||
| Q3 25 | $832.6M | $4.0B | ||
| Q2 25 | $837.2M | $4.0B | ||
| Q1 25 | $823.1M | $4.0B | ||
| Q4 24 | $893.3M | $4.1B | ||
| Q3 24 | $867.9M | $4.1B | ||
| Q2 24 | $882.0M | $4.2B |
负债/权益比OFIXPDM
| Q1 26 | — | — | ||
| Q4 25 | — | 1.49× | ||
| Q3 25 | 0.36× | 1.43× | ||
| Q2 25 | 0.34× | 1.41× | ||
| Q1 25 | 0.34× | 1.40× | ||
| Q4 24 | 0.31× | 1.40× | ||
| Q3 24 | 0.23× | 1.36× | ||
| Q2 24 | 0.22× | 1.34× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | — |
| 自由现金流经营现金流 - 资本支出 | $16.8M | — |
| 自由现金流率自由现金流/营收 | 7.6% | — |
| 资本支出强度资本支出/营收 | 4.9% | 110.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | — |
8季度趋势，按日历期对齐
经营现金流OFIXPDM
| Q1 26 | — | — | ||
| Q4 25 | $27.7M | $140.6M | ||
| Q3 25 | $12.4M | $35.8M | ||
| Q2 25 | $11.6M | $50.1M | ||
| Q1 25 | $-18.4M | $3.7M | ||
| Q4 24 | $23.7M | $198.1M | ||
| Q3 24 | $11.7M | $42.9M | ||
| Q2 24 | $9.0M | $66.8M |
自由现金流OFIXPDM
| Q1 26 | — | — | ||
| Q4 25 | $16.8M | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $-25.1M | — | ||
| Q4 24 | $15.2M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $-360.0K | — |
自由现金流率OFIXPDM
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | -13.0% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | -0.2% | — |
资本支出强度OFIXPDM
| Q1 26 | — | 110.3% | ||
| Q4 25 | 4.9% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 3.5% | — | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 4.7% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
PDM
暂无分部数据
